Citations refer to the original publication, not to a Scieee localized version.
Schadendorf, D., Luke, J. J., Ascierto, P. A., Long, G. V., Rutkowski, P., Khattak, A., Cruz Merino, L. D. L., & Scolyer, R. A. (2024). Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. BMC. https://doi.org/10.1136/jitc-2023-007501
Schadendorf, Dirk, et al. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. BMC, 2024. https://doi.org/10.1136/jitc-2023-007501.
Schadendorf, Dirk, Jason John Luke, Paolo A. Ascierto, Georgina V. Long, Piotr Rutkowski, Adnan Khattak, Luis de la Cruz Merino, and Richard A. Scolyer. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. BMC, 2024. https://doi.org/10.1136/jitc-2023-007501.
Schadendorf, D. et al. (2024) Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. BMC. Available at: https://doi.org/10.1136/jitc-2023-007501.
D. Schadendorf et al., “Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial,” BMC, 2024, doi: 10.1136/jitc-2023-007501.
@misc{schadendorf2024pembrolizumab,
author = {Schadendorf, Dirk and Luke, Jason John and Ascierto, Paolo A. and Long, Georgina V. and Rutkowski, Piotr and Khattak, Adnan and Cruz Merino, Luis de la and Scolyer, Richard A.},
title = {Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial},
year = {2024},
publisher = {BMC},
doi = {10.1136/jitc-2023-007501},
url = {https://doi.org/10.1136/jitc-2023-007501}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
